Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GLS

Gelesis (GLS) Stock Price, News & Analysis

Gelesis logo

About Gelesis Stock (NYSE:GLS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.11
$0.33
52-Week Range
N/A
Volume
185,100 shs
Average Volume
386,034 shs
Market Capitalization
$11.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Receive GLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gelesis and its competitors with MarketBeat's FREE daily newsletter.

GLS Stock News Headlines

Gelesis Holdings Inc GLSHQ
“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
GLS Gelesis Holdings, Inc.
See More Headlines

GLS Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Gelesis investors own include VIQ Solutions (VQS), Faraday Future Intelligent Electric (FFIE), Eos Energy Enterprises (EOSE), Danimer Scientific (DNMR), Crown ElectroKinetics (CRKN), Boxed (BOXD) and BitNile Metaverse (BNMV).

Company Calendar

Today
5/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:GLS
Phone
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$56.03 million
Net Margins
-221.38%
Pretax Margin
-214.62%

Debt

Sales & Book Value

Annual Sales
$25.77 million
Price / Cash Flow
N/A
Book Value
($0.34) per share
Price / Book
N/A

Miscellaneous

Free Float
64,606,000
Market Cap
$11.63 million
Optionable
Not Optionable
Beta
0.88
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSE:GLS) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners